Literature DB >> 6783531

Candidacidal activity of mouse macrophages in vitro.

P K Maiti, R Kumar, L N Mohapatra.   

Abstract

Mouse peritoneal macrophages were infected in vitro with Candida albicans, and the phagocytic and candidacidal activities were estimated by microscopic examination of Giemsa-stained cells. Activated macrophages obtained from either BCG-vaccinated animals or by in vitro exposure of normal macrophages to phytohemagglutinin-induced lymphokines exhibited higher phagocytic and candidacidal activities than did normal macrophages. However, activated macrophages obtained by in vitro exposure of macrophages to candida-induced lymphokines exhibited the highest phagocytic and candidacidal activities. The incorporation of immune mouse serum into the culture medium also enhanced the phagocytic and candidacidal activities of the normal macrophages but failed to improve the function of the activated macrophages. These results suggest that both activated macrophages and antibodies may be required for controlling candida infections in mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6783531      PMCID: PMC551142          DOI: 10.1128/iai.29.2.477-482.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Enhancement of macrophage bactericidal capacity by antigenically stimulated immune lymphocytes.

Authors:  H B Simon; J N Sheagren
Journal:  Cell Immunol       Date:  1972-06       Impact factor: 4.868

2.  The cellular immune defect in chronic mucocutaneous candidiasis.

Authors:  R A Chilgren; H J Meuwissen; P G Quie; R A Good; R Hong
Journal:  Lancet       Date:  1969-06-28       Impact factor: 79.321

3.  Activation of T and B lymphocytes by insoluble phytomitogens.

Authors:  M F Greaves; S Bauminger
Journal:  Nat New Biol       Date:  1972-01-19

4.  The host response to Calmette-Guérin bacillus infection in mice.

Authors:  R V Blanden; M J Lefford; G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

5.  Passive immunization of mice against Candida albicans.

Authors:  S Mourad; L Friedman
Journal:  Sabouraudia       Date:  1968-02

6.  Interaction of Candida albicans with human leukocytes and serum.

Authors:  R I Lehrer; M J Cline
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

7.  Application of agglutinins for the rapid and accurate identification of medically important Candida species.

Authors:  C E Sweet; L Kaufman
Journal:  Appl Microbiol       Date:  1970-05

8.  Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.

Authors:  H B Simon; J N Sheagren
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

9.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites.

Authors:  T C Jones; J G Hirsch
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  13 in total

1.  Pulmonary clearance of Candida albicans: effect of exposure to native and metal-coated fly ash.

Authors:  R Bajpai; M Waseem; S Dogra; J L Kaw
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 2.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  In vitro determination of phagocytic indices of Candida berkhout species by rat peritoneal macrophages.

Authors:  R Salim; A van Gelderen de Komaid
Journal:  Mycopathologia       Date:  1985-01       Impact factor: 2.574

4.  Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.

Authors:  D M Anderson; M A Dykstra
Journal:  Mycopathologia       Date:  1984-06-30       Impact factor: 2.574

5.  Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.

Authors:  T Decker; M L Lohmann-Matthes; M Baccarini
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 6.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

7.  In vitro modification of Candida albicans invasiveness.

Authors:  S E Fontenla de Petrino; M E de Jorrat; A Sirena; J C Valdez; O Mesón
Journal:  Mycopathologia       Date:  1986-05       Impact factor: 2.574

8.  Role of antibodies and effect of BCG vaccination in experimental candidiasis in mice.

Authors:  P K Maiti; A Kumar; R Kumar; L N Mohapatra
Journal:  Mycopathologia       Date:  1985-08       Impact factor: 2.574

9.  Clearance and killing of Candida albicans in the perfused mouse liver.

Authors:  L R Schwocho; R J Moon
Journal:  Mycopathologia       Date:  1981-12-11       Impact factor: 2.574

10.  Immunomodulation by Blastomyces dermatitidis: functional activity of murine peritoneal macrophages.

Authors:  L S McDaniel; G C Cozad
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.